tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Schmidt, 26 are a BUY (100%).
Analyst Eric Schmidt, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 52.68% that have a potential upside of 33.83% achieved within 1005 days.
Eric Schmidt’s has documented 52 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 27-Sep-2024.
Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for BIIB (BIOGEN) at 1/2/2018. The price target of $338 was fulfilled within 1 day with a profit of $3.83 (1.15%) receiving and performance score of 11.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$300
$139.24 (86.61%)
$294
6 days ago
(15-Nov-2024)
21/29 (72.41%)
$139.24 (86.61%)
236
Hold
$190
$29.24 (18.19%)
$260
7 days ago
(14-Nov-2024)
12/19 (63.16%)
$21.4 (12.69%)
180
Hold
$210
$49.24 (30.63%)
$240
17 days ago
(04-Nov-2024)
1/3 (33.33%)
$35.64 (20.44%)
26
Buy
$204
$43.24 (26.90%)
$373
21 days ago
(31-Oct-2024)
21/40 (52.5%)
$30 (17.24%)
286
Buy
$275
$114.24 (71.06%)
$305
21 days ago
(31-Oct-2024)
11/17 (64.71%)
$101 (58.05%)
162
Which stock is Eric Schmidt is most bullish on?
Which stock is Eric Schmidt is most reserved on?
What Year was the first public recommendation made by Eric Schmidt?
